Back to search

France· FR:67961885

MALOCIDE 50 mg, comprimé

A pyrimethamine product containing pyriméthamine, registered in France by SANOFI WINTHROP INDUSTRIE, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC P01BD01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedMALOCIDE 50 mg, compriméATCP01BD01REGISTER NO.FR:67961885PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Pyrimethamine is registered in 9 of 19 countries.

Countries holding a registration under ATC P01BD01 (pyrimethamine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose

Pyrimethamine · ATC P01BD01

9 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pyrimethamine costs, country by country.

Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.97 in France to $3.75 in Switzerland — a ×3.9 gap.

  • France: $0.97 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Pyrimethamine · price per daily dose (75 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.75
  • FR France$0.97
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PYRIMÉTHAMINE
Manufacturer
SANOFI WINTHROP INDUSTRIE
Country
France (FR)
ATC code
P01BD01
ATC class
Pyrimethamine
Defined daily dose
75 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930645789
    plaquette(s) thermoformée(s) PVC aluminium de 20 comprimé(s)
    EUR 11.4

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

48 interactions on record for pyrimethamine.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pyrimethamine · interactions on record

48 records

  • 4 severe
  • 28 moderate
  • 2 minor
  • 14 info

Most severe, free to view

  • Sodium aurothiomalateM01CB01severe
  • AuranofinM01CB03severe
  • AurothioglucoseM01CB04severe
  • DeferiproneV03AC02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pyrimethamine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pyrimethamine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Belgium · Daraprim
  • Germany · Daraprim
  • Spain · Daraprim
  • United Kingdom (Northern Ireland) · Daraprim
  • Luxembourg · Daraprim
  • Netherlands · Daraprim
  • Portugal · Pirimetamina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/320d175c-6839-4afa-9efe-61b2a588946d
GET /v1/drugs/320d175c-6839-4afa-9efe-61b2a588946d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67961885",
  "date_amm": "1997-05-02",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "PYRIMÉTHAMINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about pyrimethamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.